Introduction We present international consensus recommendations for improving diagnosis,
management and treatment access in multiple sclerosis (MS). Our vision is that these will be …

Background Cost-of-illness (COI) studies of Multiple Sclerosis (MS) are vital components for
describing the economic burden of MS, and are frequently used in model studies of …

Objective To identify predictors of 10‐year Expanded Disability Status Scale (EDSS) change
after treatment initiation in patients with relapse‐onset multiple sclerosis. Methods Using …

Background Brain disorders represent a high burden in Europe and worldwide. The
objective of this study was to provide specific estimates of the economic costs of brain …

Objective: To assess outcomes for patients treated with interferon beta-1b immediately after
clinically isolated syndrome (CIS) or after a short delay. Methods: Participants in BENEFIT …

Background Multiple sclerosis (MS) often leads to severe neurological disability and a
serious decline in quality of life. The ideal target of disease‐modifying therapy for MS is to …

Background Although the economic burden of multiple sclerosis (MS) in high-income
countries (HICs) has been extensively studied, information on the costs of MS in low-and …

Background Fatigue is one of the most debilitating symptoms in multiple sclerosis (MS)
considerably interfering with patients' daily functioning. Both researchers and clinicians …

Background Vaccines offer people with multiple sclerosis (PwMS) an effective protection
against severe COVID-19 disease courses. However, representative real-world data on the …

Objective To explore the occurrence and characteristics of aggressive multiple sclerosis
(AMS) in adult-onset multiple sclerosis (MS) patients. Methods Prospectively collected data …